About Us :
Ehsan Project (EHSAN), a phase III clinical trial, was started in 2020 with the implementation of its first round of studies. EHSAN was approved in 2019 with the support of the National Institute for Development of Medical Sciences Research of Iran (NIMAD) and the participation of Shahid Sadoughi University of Medical Sciences and Yazd Cardiovascular Research Center. In this project, we collect. processes, and analyzes data on the effect (and side effects) of the drug “Synaptazine” in people over the age of 50 diagnosed with early-stage Alzheimer's disease".
More about us :
0
Participants
0
Pls and Researchers
0
staffs Associate Specialists
Our Services :
Ehsan Project psychologists interview patients and their caregivers during the first phase of the screening. If deemed suitable, they are admitted to the study after Ehsan physicians confirm their blood tests and other medical qualifications required for admittance. In the trial phase, they are invited to the clinic once every 3 months for a year to complete a prognostic questionnaires. During the first year, Synaptazine is delivered to the patients' caregivers during the trial. All patients are insured during the period of participation in the trial.
Meeting of The research team and investigators Safayeh Hotel Yazd Feb 2020
Play Video
